Status:
COMPLETED
Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic
Lead Sponsor:
University Hospital, Linkoeping
Conditions:
COVID-19
Venous Thromboembolism
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to investigate the prevalence of venous thromboembolism in a regional health care system (Region Östergötland, Sweden) before and during the SARS-COV-2 pandemic. In a retr...
Detailed Description
In the current SARS-COV-2 pandemic there is a concern about an increased risk of venous thromboembolism (VTE) concurrent with the infection, including both pulmonary embolism (PE) and deep venous thro...
Eligibility Criteria
Inclusion
- Any patient that has done a Computer Tomography Angiography of the lungs between 1:st of March and 31:st of May each year from 2015 to 2020
- Any patient that has done a Ultrasound of the legs between 1:st of March and 31:st of May each year from 2015 to 2020
- Any patient with a new diagnosis of pulmonary embolism or deep venous thrombosis between 1:st of March and 31:st of May each year from 2015 to 2020
Exclusion
- Incomplete diagnostic examination
- Follow-up examination of know acute VTE
- Primary investigation done outside the healthcare system
- Patient \<18 years of age
Key Trial Info
Start Date :
June 8 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2020
Estimated Enrollment :
7795 Patients enrolled
Trial Details
Trial ID
NCT04400877
Start Date
June 8 2020
End Date
September 30 2020
Last Update
November 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Linköping
Linköping, Östergötland County, Sweden, 58185